THRV-NCE

N/A

Report date: 2025/06/04 14:33:16
NME

Base Information

Drug NameTHRV-NCE
Drug Alias NameTHRV-NCE
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase Sgk1 inhibitors
TargetsSerine/threonine-protein kinase Sgk1
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThryv Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesThryv Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A